WUXI BIOLOGICS UNSP/ADR (WXXWY)
WXXWY moved a median of 0.00% 30 minutes after news, and -0.17% by the close. How WXXWY actually reacts to news — the realized, point-in-time move the market made, measured across 119 labeled events over the last three years with zero look-ahead.
WXXWY’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 19% | 112 |
| 30-min | 0.00% | 41% | 115 |
| 60-min | -0.20% | 37% | 119 |
| to close | -0.17% | 38% | 112 |
| Middle 50% of WXXWY reactions | -1.36% to +0.50% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 119 |
Half of all WUXI BIOLOGICS UNSP/ADR news events land between -1.36% and +0.50% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when WXXWY moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to WXXWY's baseline. Nothing else.
Recent WXXWY events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| WuXi Biologics Receives Top-Honor Jade Award at The Asset Corporate Sustainability Leadership Awards 2026 | Press release | PR Newswire | +0.00% | — | |
| WuXi Biologics at Festival of Biologics Basel 2026: Turning Scientific Complexity into Commercial Certainty | Press release | PR Newswire | +1.17% | +0.38% | |
| WuXi Biologics Continues to Be Included in Multiple Hang Seng Sustainability Indexes, Demonstrating ESG Excellence | Press release | PR Newswire | +0.40% | -1.04% | |
| WuXi Biologics at CPHI Milan 2026: Empowering Biomanufacturing in Europe | Press release | PR Newswire | +0.00% | -1.37% | |
| WuXi Biologics Passes Another FDA GMP Inspection, Reinforcing Its Quality Track Record and Commercial Supply Reliability | Press release | PR Newswire | +3.46% | +2.08% | |
| WuXi Biologics Named to Forbes China ESG 50 List 2026 for Green CRDMO and Digital ESG Leadership | Press release | PR Newswire | -0.65% | -1.48% | |
| WuXi Biologics Reports Strong Profitable Growth in H1 2026 | Press release | PR Newswire | +0.00% | -2.00% | |
| WuXi Biologics Recognized for Industry Top Sustainable Biopharma Practices Empowering the Industry's Transformation Through Green CRDMO | Press release | PR Newswire | -0.46% | +1.53% | |
| WuXi Biologics Recognized by FTSE4Good for the Sixth Consecutive Year, Underscoring Value Creation Through Green CRDMO | Press release | PR Newswire | +0.00% | +4.66% | |
| WuXi Biologics' MFG8 Drug Substance Facility Secures FDA PLI Approval, Advancing Commercial Supply of a Potential Blockbuster Autoimmune Therapy | Press release | PR Newswire | -5.09% | -3.56% | |
| WuXi Biologics Achieves MSCI ESG AAA Rating and MSCI Selection Indexes Inclusion for Fourth Consecutive Year | Press release | PR Newswire | +0.00% | -0.11% | |
| WuXi Biologics Receives Brazil ANVISA GMP Certification to Enable Global Commercial Manufacturing of Innovative Cancer Immunotherapy | Press release | PR Newswire | -1.80% | -0.45% | |
| WuXi Biologics' 25th Drug Substance Facility Completes First GMP Production, Manufacturing Process Execution with Zero Deviations | Press release | PR Newswire | +0.50% | +1.12% | |
| WuXi Biologics' Suzhou Biosafety Testing Center Received Fourth EMA GMP Certification, Enabling 19 Commercial Products for the European Market | Press release | PR Newswire | +0.00% | -0.13% | |
| WuXi Biologics Ireland Wins Top Honors at the 2026 Life Sciences Industry Awards | Press release | PR Newswire | -1.38% | -2.51% | |
| WuXi Biologics Singapore CRDMO Hub Completes Modular Topping-Out of Drug Product Facility | Press release | PR Newswire | +0.00% | -0.77% | |
| WuXi Biologics Named to CDP Supplier Engagement Assessment A List for the Second Consecutive Year | Press release | PR Newswire | -2.07% | -2.84% | |
| WuXi Biologics Achieves GMP Release of 18th Drug Product Facility, Advancing Integrated Drug Substance to Drug Product Capabilities | Press release | PR Newswire | -3.88% | -4.34% | |
| WuXi Biologics Hosts Third CRDMO Day in Japan, Accelerating Biopharma Innovation from IND to Commercialization | Press release | PR Newswire | +0.00% | +0.20% | |
| WuXi Biologics Included in 2026 Dow Jones Best-in-Class World Index and Emerging Markets Index | Press release | PR Newswire | -1.36% | +0.00% | |
| WuXi Biologics Releases 2025 Sustainability Report, Advancing Sustainable Growth and Improving Healthcare Access | Press release | PR Newswire | +2.34% | -0.44% | |
| WuXi Biologics Chengdu Microbial Commercial Manufacturing Site Achieves Structural Completion and Key Equipment Arrival | Press release | PR Newswire | +0.00% | +4.87% | |
| WuXi Biologics Receives South Korea MFDS GMP Certification to Enable Commercial Manufacturing of Bispecific Antibody Therapeutics | Press release | PR Newswire | +0.00% | +2.52% | |
| WuXi Biologics Recognized by Morningstar Sustainalytics as Industry and Regional ESG Leader for Sixth Year | Press release | PR Newswire | +0.00% | -0.97% | |
| WuXi Biologics Achieves ISO 13485 Certification, Signifying Strong Capabilities in Drug-Device Combination Product Development and Manufacturing | Press release | PR Newswire | +1.24% | -2.47% | |
| WuXi Biologics Honored with CDMO Leadership Awards for Ninth Consecutive Year | Press release | PR Newswire | +0.00% | -2.77% | |
| WuXi Biologics Reports Record 2025 Annual Results, Operational Excellence Driven by Digital-Native Architecture | Press release | PR Newswire | +0.00% | +2.17% | |
| WuXi Biologics Reports Record 2025 Annual Results | Press release | PR Newswire | -0.29% | +2.59% | |
| World Water Day: WuXi Biologics Advances Water Stewardship and Achieves Water Target | Press release | PR Newswire | +0.24% | +3.01% | |
| WuXi Biologics Wins Multiple Asia-Pacific Biopharma Excellence Awards for Leadership in Bioprocessing, Manufacturing Excellence, and Digital Innovation | Press release | PR Newswire | +1.00% | -2.34% | |
| WuXi Biologics Included in S&P Global Sustainability Yearbook for Fourth Consecutive Year | Press release | PR Newswire | -2.92% | +0.00% | |
| WuXi Biologics Awarded EcoVadis Platinum Medal for Third Consecutive Year, Ranking Among Top 1% Globally | Press release | PR Newswire | +7.45% | +4.47% | |
| WuXi Biologics and Vertex Sign License and Research Service Agreement for T-cell Engager | Press release | Canada Newswire | +0.00% | -0.95% | |
| WuXi Biologics and Sinorda Biomedicine Enter Strategic Collaboration to Accelerate Development and Manufacturing of Innovative Bispecific Antibody | Press release | PR Newswire | +2.19% | -0.94% | |
| WuXi Biologics and HanchorBio Enter Strategic Partnership to Advance Next-Generation Bi- and Multi-Functional Fusion Protein Pipeline | Press release | PR Newswire | +0.00% | -1.40% | |
| JPM Highlights | WuXi Biologics CEO Dr. Chris Chen: Scaled CRDMO Platform Delivering Sustainable High Growth | Press release | PR Newswire | +0.00% | -2.24% | |
| WuXi Biologics Launches Industry-Leading Digital Twin Platform PatroLab™ Designed to Transform Bioprocessing and Manufacturing | Press release | PR Newswire | +0.00% | -0.54% | |
| WuXi Biologics Obtains GMP Certification from UK MHRA for Commercial Manufacturing of an Ophthalmic Biologic | Press release | PR Newswire | +1.10% | +1.30% | |
| WuXi Biologics Achieves ISO 20400 Certification, Setting Benchmark in Sustainable Procurement | Press release | PR Newswire | +0.00% | +0.38% | |
| WuXi Biologics Recognized by Hong Kong ESG Reporting Awards 2025 for Outstanding ESG Disclosure | Press release | PR Newswire | +3.73% | +8.32% | |
| WuXi Biologics Achieves CDP Highest "A" Ratings in Both Climate Change and Water Security | Press release | PR Newswire | +0.00% | -4.61% | |
| WuXi Biologics Extends Global CRDMO Network to Qatar Through Strategic MoU Signed with Qatar Free Zones Authority | Press release | PR Newswire | -1.48% | -1.35% | |
| WuXi Biologics Included in Hang Seng Corporate Sustainability Benchmark Index | Press release | PR Newswire | -9.62% | -9.62% | |
| WuXi Biologics Honored with 2025 Global Customer Value Leadership Recognition by Frost & Sullivan | Press release | PR Newswire | -3.22% | -3.02% | |
| WuXi Biologics Receives MSCI AAA ESG Rating for Third Consecutive Year | Press release | PR Newswire | -0.51% | -8.49% | |
| WuXi Biologics Launches WuXia™4.0, Targeted Integration Cell Line Platform TrueSite TI™,to Accelerate Biologics Development with High Titer and Superior Stability | Press release | PR Newswire | +0.00% | +0.98% | |
| WuXi Biologics Selected as Constituent of FTSE4Good Index Series for Fifth Consecutive Year | Press release | PR Newswire | +0.00% | -0.17% | |
| Three WuXi Biologics Manufacturing Facilities Receive GMP Certification from Türkiye Ilaç ve Tibbi Cihaz Kurumu (TITCK) | Press release | PR Newswire | +0.00% | +0.02% | |
| WuXi Biologics Achieves "CDMO of the Year" Among Three Prestigious IMAPAC Awards | Press release | PR Newswire | -3.00% | -4.21% | |
| WuXi Biologics Launches Green CRDMO White Paper to Advance Sustainability in Biologics Industry | Press release | PR Newswire | +0.00% | +1.90% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the WXXWY section they belong to.
Where else WXXWY is measured.
WXXWY earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is WUXI BIOLOGICS UNSP/ADR's median reaction calculated?
Every labeled WXXWY news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 119 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 41% of WXXWY's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does WXXWY's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.